Papers
Topics
Authors
Recent
Search
2000 character limit reached

Lancet: Precision in Medicine and Beyond

Updated 4 July 2026
  • Lancet is a polysemous term that denotes a sharpened needle tip in medicine and names a high-impact medical journal.
  • Medical research shows the SonoLancet enhances tissue yield up to 6.61× via localized ultrasonic actuation and inertial cavitation.
  • Lancet also designates precise computational methods in MoE training, LLM alignment, image editing, and filament tomography in astronomy.

“Lancet” is a polysemous technical term whose meaning depends strongly on domain. In medicine, it denotes the sharpened cutting tip of a needle and, by extension, appears in the title of a high-output general medical journal, The Lancet, which is ranked third in the General Science Ranking medical list. In current research literature, the same word or acronym is also reused for a compiler-based Mixture-of-Experts training system, two distinct large-language-model intervention frameworks, a diffusion-based image-editing method, and an astronomy project on filament evolution. The term therefore requires contextual disambiguation rather than a single domain-invariant definition (Yu, 17 May 2026, Perra et al., 2020, Jiang et al., 2024, Xu et al., 20 Feb 2026).

1. Core medical meaning: the lancet as a cutting tip

In the medical-instrument sense, the lancet is the sharpened tip of a needle whose conventional function is purely mechanical. Its converging cutting edges and sharp point shear and slice tissue during insertion or fanning. This meaning is explicit in work on ultrasonic needle actuation, where the authors describe the lancet as the tip region whose function they modify rather than the shaft or lumen (Perra et al., 2020).

That work converts a standard 21G × 80 mm hypodermic needle into an ultrasonic tip termed the “SonoLancet” by coupling a Langevin transducer to the needle through an S-shaped aluminum waveguide. Numerical simulation showed that time-averaged acoustic intensity is maximized within a few millimeters of the tip and is more than double the intensity along the lumen. The resulting nonlinear ultrasonics were localized to the bevel yet extended their effects several millimeters beyond the physical needle boundary. Quantified phenomena included inertial cavitation confined to less than 2 mm from the tip, cavitation probability up to 50% in the hot-spot region, bubble-driven flows up to 5 m/s, and boundary accelerations up to 20,000 g. In ex vivo fine-needle biopsy, the SonoLancet increased tissue yield by 3.75×3.75\times to 6.61×6.61\times across spleen, liver, kidney, and muscle at the highest reported total acoustic power, while histology showed intact cells and tissue constructs and fragmentation metrics were not significantly different at the stated Bonferroni-corrected threshold (Perra et al., 2020).

This instrument-centered usage is the historically primary one within the supplied material. It also clarifies later metaphorical reuse: several computational systems named “Lancet” invoke the idea of precise, localized intervention rather than any literal relation to needles.

2. The Lancet as a medical journal in bibliometric ranking

In the journal sense, The Lancet appears in the General Science Ranking, an open-source, citation-normalized venue-classification system built on OpenAlex and Semantic Scholar. Within the GSR medical list, The Lancet is ranked 3rd among medical journals, assigned to Q1, and given a composite GSR score of 27.61. Its reported field-weighted citation impact is 26.73, computed as the arithmetic mean of OpenAlex paper-level FWCI values across 2022–2024 Article/Review papers after filtering out missing, zero-valued, and non-research items. Only CA: A Cancer Journal for Clinicians and New England Journal of Medicine are ranked above it in the reported medical ordering (Yu, 17 May 2026).

GSR’s scoring function is explicitly multidimensional:

score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).

For journals, IF2 is computed from actual OpenAlex yearly citation counts rather than an approximation. With t=2025t=2025,

IF22025=citations in 2025 to Article/Review items published in 2023 and 2024citable Article/Review items published in 2023 and 2024.IF2_{2025}=\frac{\text{citations in 2025 to Article/Review items published in 2023 and 2024}}{\text{citable Article/Review items published in 2023 and 2024}}.

The Lancet’s specific IF2, h5h5, and citation CAGR are not numerically printed in the paper, and the paper does not report whether a self-citation penalty was applied to this venue. Its score nevertheless places it far above the reported Q1/Q2 boundary of 5.24/5.23, so its Q1 status is not marginal but structurally secure within the fixed-quota partitioning scheme (Yu, 17 May 2026).

The ranking framework matters because it is designed for policy use under open-data constraints. GSR targeted 500 medical journals and scored 489 of them, with FWCI available for 95.9% of medical-journal papers and citation CAGR computable for 95.1% of journals. Quartiles are absolute rank intervals rather than moving percentiles: Q1 spans ranks 1–50, Q2 51–100, Q3 101–200, and Q4 201+. This design was introduced to avoid percentile volatility when the corpus changes. At the aggregate level, GSR Q1 agrees with JCR Q1 for 84% of 350 medical journals, with Cohen’s κ=0.71\kappa=0.71, but the paper does not itself state The Lancet’s JCR quartile and therefore does not formally assert one-to-one concordance for that specific venue (Yu, 17 May 2026).

3. Statistical reliability of results reported in The Lancet

A distinct line of work examines The Lancet not as a venue-ranking object but as a source of statistical claims. Jager and Leek estimated false positive rates among reported significant results in abstracts from five major medical journals between 2000 and 2010 by scraping PubMed abstracts for reported PP-values and modeling their distribution. For The Lancet, the estimated false positive rate among reported significant results was 19% with standard deviation 3%, higher than New England Journal of Medicine at 11% and comparable to JAMA and BMJ at 17% each. The paper also reports that 80% of reported PP-values in The Lancet abstracts were below 0.05 (Jager et al., 2013).

The statistical model treats observed significant PP-values as draws from a mixture of a null component and a true-positive component:

6.61×6.61\times0

where 6.61×6.61\times1 on 6.61×6.61\times2 corresponds to 6.61×6.61\times3 under the null, and 6.61×6.61\times4 is a truncated Beta density on the same interval. The authors further account for reporting artifacts by modeling inequality-reported values such as 6.61×6.61\times5 as censored observations and rounded values such as 6.61×6.61\times6 or 6.61×6.61\times7 as grouped outcomes in a multinomial extension. Parameters are estimated by EM rather than by Storey’s estimator or 6.61×6.61\times8-value computation, which the paper discusses only for context (Jager et al., 2013).

Two interpretive cautions are central. First, the estimate applies only to reported significant 6.61×6.61\times9-values appearing in abstracts, not to all statistical tests in full articles. Second, the inferred quantity is not the same as a replication probability for any individual paper. Within those limits, the results do not support the claim that most published medical research is false. The paper’s overall estimate across the five journals is 14% false positives among reported results, and the mixed-effects analysis finds no significant increase over time, with an estimated slope of about 0.5% more false positives per year and score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).0. Submission volume was likewise not significantly associated with increasing false positive rates, with about 0.1% more false positives per 100 submissions and score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).1 (Jager et al., 2013).

4. The Lancet as a source of clinically realistic AI evaluation data

In recent medical-AI evaluation, The Lancet also functions as a source corpus for challenging question-answering benchmarks. The paper “A Preliminary Study of o1 in Medicine” constructs LancetQA by crawling The Lancet picture quiz gallery and curating 200 English, single-best-answer multiple-choice questions focused on patient diagnosis based on symptoms. Ground-truth labels are taken from the professional quiz materials. The authors describe LancetQA and NEJMQA as “newly constructed and more challenging” than standard benchmarks such as MedQA, with greater clinical relevance because they are derived from professional case challenges rather than exam-style datasets (Xie et al., 2024).

A common misconception would be to treat LancetQA as a multimodal benchmark because its source is a picture quiz gallery. The reported evaluation is not image-based. The paper states that no image usage is reported for LancetQA in this study; instead, the benchmark is evaluated as text-only medical multiple-choice QA. No training or validation split is reported, no fine-tuning on Lancet content is performed, and the main metric is Accuracy:

score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).2

No confidence intervals, calibration metrics, or statistical significance tests are reported for LancetQA (Xie et al., 2024).

Quantitatively, o1 achieved 81.5% accuracy on LancetQA, compared with 76.0% for GPT-4 and 61.0% for GPT-3.5. Explicit chain-of-thought prompting increased o1 to 85.5% and GPT-4 to 81.5%. For o1, self-consistency combined with chain-of-thought yielded 84.5%, while Reflexion degraded performance sharply to 61.0%. The paper interprets these results as evidence that improved reasoning benefits clinical QA, but it simultaneously identifies persistent weaknesses, including hallucination, prompt sensitivity, and limitations of current evaluation protocols. For LancetQA specifically, the absence of specialty-level reporting, uncertainty quantification, and multimodal assessment constrains claims about clinical deployment (Xie et al., 2024).

5. “Lancet” and “LANCET” as names for computational methods

In computer systems research, “Lancet” names a compiler-based accelerator for Mixture-of-Experts training. Its target problem is extended all-to-all latency in expert-parallel MoE models. Rather than overlapping communication only with expert computation, the system broadens overlap to the whole training graph: in the forward pass it partitions and pipelines non-MoE and MoE computations with irregular all-to-all, and in the backward pass it schedules independent weight-gradient computations to cover earlier all-to-all operations. Implemented as RAF compiler passes, it reportedly reduces non-overlapping communication time by up to 77% relative to state-of-the-art baselines and achieves end-to-end speedups up to score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).3, with cost-model prediction error around 3.83% and optimization time typically under 20 minutes per model (Jiang et al., 2024).

In large-language-model faithfulness research, “LANCET” is expanded as “Neural Intervention via Structural Entropy for Mitigating Faithfulness Hallucinations in LLMs.” This framework treats hallucinations as propagation phenomena rather than isolated neuron failures. It first ranks hallucination-prone “instigator” neurons by a gradient-based contrastive score,

score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).4

then builds a Hallucination Difference Ratio graph, partitions it by minimizing structural entropy, and finally applies hierarchical, topology-aware suppression while protecting critical reasoning circuits. On LLaMA2-7B-Chat, reported results improve PDTB Overall from 17.4 to 27.6 and TruthfulQA True*Info from 57.6 to 67.8; on DeepSeek-LLM-7B, PDTB Overall rises from 15.1 to 23.7 and TruthfulQA True*Info from 59.5 to 72.8. The paper presents this as overcoming the factuality–faithfulness trade-off seen in stronger but coarser interventions such as TruthX (Wang et al., 4 Jan 2026).

A different LLM-alignment paper reuses the acronym as “LLM BehAvior Correction with INfluence FunCtion REcall and Post-Training.” Here the objective is not faithfulness to provided context but correction of undesirable behaviors induced by outdated or unsafe training data. LANCET has two phases: influence-based recall, scaled by LinFAC rather than EK-FAC, and Influence function-driven Bregman Optimization, which uses influence-ranked positive and negative training samples in a pairwise objective regularized by a Bregman divergence and parameter proximity term. On Safe RLHF with Llama 3.1-8B, the paper reports a human Likert score of 5.82 for LANCET versus 3.12 for the impure model, 4.12 for SFT+ER, and 4.64 for DPO+ER. On Anthropic-HH it reports an average harmfulness reduction of 16.8% with only 2.6% utility reduction, and on BeaverTails with OPT/Llama2 it reports about 21.1% harmfulness reduction with about 1.1% utility loss (Zhang et al., 2024).

In diffusion-based image editing, “Concept Lancet” or “CoLan” denotes a zero-shot, plug-and-play framework for compositional representation transplant. It decomposes a source latent score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).5 in text-embedding or diffusion-score space over a task-specific dictionary score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).6 via sparse coding,

score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).7

then replaces, adds, or removes concepts by swapping dictionary atoms while preserving the learned coefficients. CoLan-150K supplies 5,078 visually grounded concepts and 152,971 textual stimuli. On PIE-Bench, CoLan-equipped baselines improve both consistency and edit effectiveness relative to vector-addition baselines, while sparse-coding overhead is reported as only 0.153 s for P2P-Zero and 0.084 s for InfEdit (S). The paper explicitly states that this use of “Lancet” is unrelated to the medical journal or the surgical instrument (Luo et al., 3 Apr 2025).

Taken together, these papers show that the name is reused independently across computational subfields. The shared semantic motif is precision: graph-level scheduling in MoE training, topology-aware neural intervention for hallucination mitigation, influence-targeted behavior correction, and concept-local editing in diffusion models.

6. LANCET in astronomy: filament and cluster evolution tomography

In Galactic star-formation studies, LANCET expands to “Linear filament and nested cluster evolution tomography.” The project aims to recover a dynamic, variable-controlled view of mass assembly by selecting single elongated filaments whose contiguous subregions span distinct evolutionary stages under common distance and environmental conditions. Its first target, the G316.8 filament, is a nearly linear structure about 14 pc long at score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).8 kpc, with three contiguous subregions representing a sequence from an infrared dark cloud through a massive young stellar object region to an H II region, each with molecular gas reservoirs of order score=0.35×FWCImean+0.35×IF2effective+0.15×log(1+h5)+0.15×log(1+max(cite_CAGR,0)).\text{score} = 0.35 \times \text{FWCI}_{\text{mean}} + 0.35 \times \text{IF2}_{\text{effective}} + 0.15 \times \log(1+h5) + 0.15 \times \log(1+\max(\text{cite\_CAGR},0)).9 (Xu et al., 20 Feb 2026).

The project mapped the full filament with the Atacama Compact Array at 1.3 mm, covering t=2025t=20250 at 0.08 pc resolution after combination with Herschel and APEX/ArTéMiS data. Structural evolution was quantified with dendrogram-based dense-fragment statistics, column-density PDFs, and t=2025t=20251-variance analysis. Across the young, intermediate, and evolved subregions, the maximum fragment mass increases from t=2025t=20252 to t=2025t=20253 to t=2025t=20254, while the dense-gas mass fraction above t=2025t=20255 rises from 0.4% to 2.3% to 9.6%. The N-PDF evolves from a single power-law tail with a cutoff near t=2025t=20256 in the quiet region to a flatter primary tail plus a second steep tail near t=2025t=20257 in the active region. Over the same sequence, t=2025t=20258-variance slopes become progressively shallower, from t=2025t=20259 and IF22025=citations in 2025 to Article/Review items published in 2023 and 2024citable Article/Review items published in 2023 and 2024.IF2_{2025}=\frac{\text{citations in 2025 to Article/Review items published in 2023 and 2024}}{\text{citable Article/Review items published in 2023 and 2024}}.0 in the young region to IF22025=citations in 2025 to Article/Review items published in 2023 and 2024citable Article/Review items published in 2023 and 2024.IF2_{2025}=\frac{\text{citations in 2025 to Article/Review items published in 2023 and 2024}}{\text{citable Article/Review items published in 2023 and 2024}}.1 and IF22025=citations in 2025 to Article/Review items published in 2023 and 2024citable Article/Review items published in 2023 and 2024.IF2_{2025}=\frac{\text{citations in 2025 to Article/Review items published in 2023 and 2024}}{\text{citable Article/Review items published in 2023 and 2024}}.2 in the evolved region, indicating increasing small-scale density contrast (Xu et al., 20 Feb 2026).

This astronomical usage is conceptually distinct from the medical and computational ones. It does not denote a tool for localized intervention but a tomography program for controlled evolutionary comparison. A plausible implication is that the reuse of the acronym reflects the same rhetorical preference for sharp, selective probing, but the paper’s technical substance is astrophysical: multi-resolution continuum fusion, dense-gas diagnostics, and planned ALMA 12 m follow-up to approximately 800 AU scale (Xu et al., 20 Feb 2026).

Topic to Video (Beta)

No one has generated a video about this topic yet.

Whiteboard

No one has generated a whiteboard explanation for this topic yet.

Follow Topic

Get notified by email when new papers are published related to Lancet.